-inc-logo-1200x675.png){kind=logo}
Mind Medicine (MindMed) Inc. (OTCMKTS:MMEDF – Get Free Report) rose 1% during trading on Thursday . The stock traded as high as $7.21 and last traded at $6.82. Approximately 1,281,924 shares traded hands during trading, a decline of 62% from the average daily volume of 3,376,665 shares. The stock had previously closed at $6.75.
Mind Medicine (MindMed) Price Performance
The stock has a 50-day simple moving average of $7.52 and a 200-day simple moving average of $6.91.
Mind Medicine (MindMed) Company Profile
Mind Medicine (MindMed) Inc, a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC.
Featured Stories
- Five stocks we like better than Mind Medicine (MindMed)
- How to Effectively Use the MarketBeat Ratings Screener
- 5 Best Gold ETFs for March to Curb Recession Fears
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- 3 Stocks for Your Watchlist: Unlocking Tomorrow’s Winners Today
- What is Insider Trading? What You Can Learn from Insider Trading
- Why Smart Investors Are Watching These 3 Undervalued Stocks
Receive News & Ratings for Mind Medicine (MindMed) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mind Medicine (MindMed) and related companies with MarketBeat.com's FREE daily email newsletter.
